AddLife AB (OSTO:ALIF B)
kr 113 -0.5 (-0.44%) Market Cap: 13.77 Bil Enterprise Value: 19.03 Bil PE Ratio: 173.85 PB Ratio: 2.67 GF Score: 72/100

Q1 2022 AddLife AB Earnings Call Transcript

Apr 28, 2022 / 08:00AM GMT
Release Date Price: kr219.4 (-5.43%)
Kristina Willgard;publ;President;CEO
AddLife AB

()-&

My name is Kristina Willgard. I'm very happy to present to you the interim report. I think it's a very strong report for the first quarter. And if we look on the highlights for this quarter, we did right -- it was a successful quarter because still, I think we do a very good -- both sales growth but also a profit growth in this quarter. You see when you look into the report that the acquisitions are driving the sales in Medtech, which is actually exactly what we expected. You know that we have done a lot of acquisitions during the last 2 years within our MedTech business area. If we exclude the sales with COVID-19 products, we actually had an underlying organic growth of 5% in this quarter, which I think also is very strong. And both business areas actually had a positive growth, excluding COVID sales. We have completed 2 acquisitions in the quarter that was of MBA and Telia and another 2 was finalized after the quarter, and that was OâFlynn and BioCat.

So summarizing this quarter, we had

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot